Business Wire
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
📈
AI Sentiment
Highly Positive
8/10
- Home
- CERS
CERS
Cerus Corporation
as of 12-12-2025 3:45pm EST
$2.17
+$0.02
+0.70%
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Chart Type:
Time Range:
| Founded: | 1991 | Country: | United States |
| Employees: | N/A | City: | CONCORD |
| Market Cap: | 276.0M | IPO Year: | 1997 |
| Target Price: | $4.00 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.12 - $2.25 | Next Earning Date: | 11-06-2025 |
| Revenue: | $199,191,000 | Revenue Growth: | 13.03% |
| Revenue Growth (this year): | 25.31% | Revenue Growth (next year): | 9.50% |
AI-Powered CERS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 71.62%
71.62%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Cerus Corporation (CERS)
Jensen Chrystal
Sell
Chief Legal Officer
CERS Nov 24, 2025
Avg Cost/Share
$1.70
Shares
55,000
Total Value
$93,500.00
Owned After
728,294
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Jensen Chrystal | CERS | Chief Legal Officer | Nov 24, 2025 | Sell | $1.70 | 55,000 | $93,500.00 | 728,294 |
Latest Cerus Corporation News
CERS Breaking Stock News: Dive into CERS Ticker-Specific Updates for Smart Investing
Compare CERS vs Leading Stocks
See how CERS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CERS Cerus Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.